Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial)

British Journal of Surgery

Volumn 96, Issue 10, 2009, Pages 1147-1156

  Michaels, J A ^a,e   Campbell, B ^d   King, B ^c   Palfreyman, S J ^a   Shackley, P ^a   Stevenson, M ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c Sheffield West Primary Care Trust   (United Kingdom)

^d ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^e NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; SILVER DERIVATIVE;

AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; COMPRESSION THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; FEMALE; HUMAN; LEG ULCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; ULCER HEALING; WOUND DRESSING;

AGED; ANTI-INFECTIVE AGENTS, LOCAL; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCLUSIVE DRESSINGS; PROSPECTIVE STUDIES; QUALITY-ADJUSTED LIFE YEARS; REGRESSION ANALYSIS; SILVER COMPOUNDS; TREATMENT OUTCOME; VARICOSE ULCER; WOUND HEALING;

EID: 70350090274     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6786     Document Type: Article

References (28)

1. Cullum N, Nelson EA, Fletcher AW, Sheldon TA. Compression for venous leg ulcers. Cochrane Database Syst Rev 2005; (2)CD00265.
2. Palfreyman SJ, Lochiel R, Michaels JA. A systematic review of compression therapy for venous leg ulcers. Vasc Med 1998; 3: 301-313. (Pubitemid 29101671)
3. Chambers H, Dumville JC, Cullum N. Silver treatments for leg ulcers: a systematic review. Wound Repair Regen 2007; 15: 165-173. (Pubitemid 46376377)
4. Palfreyman S, Nelson EA, Michaels JA. Dressings for venous leg ulcers: systematic review and meta-analysis. BMJ 2007; 335: 244. (Pubitemid 47262423)
5. MA Healthcare Ltd. Wound Care Handbook 2008-2009. MA Healthcare: London, 2008.
6. Lansdown AB, Willams A, Chandler S, Benfield S. Silver absorption and antibacterial efficacy of silver dressings. J Wound Care 2005; 14: 155-160.
7. BMJ Group. BNF. British National Formulary 2008. http://www.bnf.org/bnf/ bnf/55/104946.htm [accessed 1 July 2008].
8. Jull A, Parag V, Molan P, Rodgers A. Randomized clinical trial of honey-impregnated dressings for venous leg ulcers. Br J Surg 2008; 95: 175-182.
9. White R, Cutting KF. Exploring the effects of silver in wound management - what is optimal? Wounds 2006; 18: 307-314.
10. Leaper DJ. Silver dressings: their role in wound management. Int Wound J 2006; 3: 282-294.
11. National Prescribing Centre. Modern Wound Dressings: the Absence of Evidence, 31. NHS, MeReC Extra: Liverpool, 2008.
12. Morrell CJ, Walters S, Dixon S, Collins KA, Brereton LM, Peters J et al. Cost-effectiveness of community leg ulcer clinics: a randomised controlled trial. BMJ 1998; 316: 1487-1491. (Pubitemid 28224956)
13. Royal College of Nursing (RCN). The Management of Patients with Venous Leg Ulcers. RCN: London, 2006.
14. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997; 35: 1095-1108. (Pubitemid 127453463)
15. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004; 42: 851-859. (Pubitemid 39456916)
16. Michaels J, Campbell WB, King B, McIntyre J, Palfreyman SJ, Shackley P et al. A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial. HMSO, NHS HTAP: London, 2009; (in press).
17. Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency. Health Econ 2004; 13: 1203-1210. (Pubitemid 40017242)
18. O'Brien BJ, Briggs AH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res 2002; 11: 455-468.
19. Fenwick E, Claxton K, Sculpher M. Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 2001; 10: 779-787. (Pubitemid 34041389)
20. Claxton K, Sculpher M, McCabe C, Briggs AH, Buxton M, Brazier J. Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra. Health Econ 2005; 14: 339-347. (Pubitemid 40514748)
21. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. John Wiley: New York, 1989.
22. Iglesias C, Birks Y, Nelson E, Scanlon E, Cullum NA. Quality of life of people with venous leg ulcers: a comparison of the discriminative and responsive characteristics of two generic and a disease specific instruments. Qual Life Res 2005; 14: 1705-1718. (Pubitemid 40978479)
23. Ellison DA, Hayes L, Lane C, Tracey A, McCollum CN. Evaluating the cost and efficacy of leg ulcer care provided in two large UK health authorities. J Wound Care 2002; 11: 47-51.
24. Moffatt CJ, Franks PJ, Doherty DC, Martin R, Blewett R, Ross F. Prevalence of leg ulceration in a London population. QJM 2004; 97: 431-437.
25. Srinivasaiah N, Dugdall H, Barrett S, Drew PJ. A point prevalence survey of wounds in north-east England. J Wound Care 2007; 16: 413-416.
26. Knight S. Could leg ulcer service provision in the community be improved? J Commun Nursing 2008; 13(Suppl): S39-S46.
27. Walters SJ, Morrell CJ, Dixon S. Measuring health-related quality of life in patients with venous leg ulcers. Qual Life Res 1999; 8: 327-336. (Pubitemid 29369637)
28. Wang J, Smith J, Babidge W, Maddern G. Silver dressings versus other dressings for chronic wounds. J Wound Care 2007; 16: 352-356.